David M. Faleck

2.3k citations
41 papers · 874 indexed · h-index 16
Topics
Cancer Immunotherapy and Biomarkers (21 papers)Microscopic Colitis (15 papers)Inflammatory Bowel Disease (14 papers)

In The Last Decade

David M. Faleck

39 papers receiving 868 citations

Peers

David M. Faleck
Comparison fields: 5 of 69
  • Oncology 386
  • Epidemiology 283
  • Genetics 195
  • Pulmonary and Respiratory Medicine 192
  • Surgery 178
Replace Giuseppe Aimo with:
Giuseppe Aimo Italy
Tadashi Yokoyama Japan
Vincenzo Imperatore Italy
Scott M. Browning United States
Ahmet Çöker Türkiye
Selda Seçkın Türkiye
Xiaoyan Liao United States
I. D. Ansell United Kingdom
Samuel M. Mahaffey United States
Kazuhiko Yoshioka Japan
David M. Faleck relative to Giuseppe Aimo Italy Giuseppe Aimo's profile →
Citations per field
00.5×10×20×30×39.3×
Giuseppe Aimo · 1×
Citations per year

Countries citing papers authored by David M. Faleck

Since Specialization
Citations

This map shows the geographic impact of David M. Faleck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Faleck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Faleck more than expected).

Fields of papers citing papers by David M. Faleck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Faleck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Faleck. The network helps show where David M. Faleck may publish in the future.

Co-authorship network of co-authors of David M. Faleck

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Faleck. A scholar is included among the top collaborators of David M. Faleck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Faleck. David M. Faleck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 5
4 1
5 3
6 17
7 5
8 6
9 13
10 3
11 3
12 38
13 74
14 20
15 17
16 184
17 47
18 36
19 16
20 25

About David M. Faleck

David M. Faleck is a scholar working on Oncology, Epidemiology and Genetics, having authored 41 papers that have together received 874 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Microscopic Colitis (15 papers) and Inflammatory Bowel Disease (14 papers). The work is most often cited by research in Oncology (386 citations), Gastroenterology (54 citations) and Urology (62 citations). David M. Faleck has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Franck Carbonnel, Clélia Coutzac, Caroline Robert, Michael Collins, Émilie Soularue, Nathalie Chaput, Patricia Lepage, Lysiane Marthey, Jean Frederic Colombel and A. Ari Hakimi. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026